Deep Tech Can Help Shape the New Reality

Boston Consulting Group (BCG) has analyzed the potential of deep technology to shape the future, particularly in the context of crises such as the COVID-19 pandemic. The consultancy notes that deep technologies, often developed by university spin-off startups, are characterized by their novelty, potential impact, lengthy development times, and significant funding requirements.

The analysis points to companies like Moderna and Ginkgo Bioworks as prime examples. Moderna's rapid development of a COVID-19 vaccine candidate and Ginkgo Bioworks' support in optimizing the manufacturing process for mRNA vaccines illustrate the functioning of the deep tech ecosystem. These companies and their underlying technologies demonstrate the significant role deep tech can play in societal and business advancement, a role that may be accelerated by current global challenges.

BCG emphasizes that deep tech companies rely on an ecosystem comprising other startups, universities, government agencies, venture capitalists, foundations, and established corporations. While the life sciences and biotech ecosystem is the most advanced, the potential in other deep tech areas is vast for both the near and long term.

The analysis indicates substantial projected growth for deep tech markets, such as synthetic biology, in the coming years. These technologies are positioned to offer solutions to global challenges and drive innovation across various sectors.